neosim AG
autonomous lung simulators

Baby Lung Simulator LuSi


in the body of a 2500g silicone baby

in the body of a 2500g silicone baby

LuSi was developped to train clinicians in the assessment of lung function and the application of respiratory therapy without risk to patients. LuSi enables risk-free training of

Perfect to train application of NCPAP, high flow oxygen therapy, invasive ventilation,high frequency ventilation, effects of surfactant therapy, interpretation of ventilator data,ventilator alarm setting

Uses of LuSi

Uses of LuSi

LuSi can be used in the hospital setting or out of hospital in any training facility because it does not need CO2 gas nor actual monitoring equipment. The vital signs parameters are calculated based on actually measured values such as pressure, flow and volume plus case-specific pathology like dead space, CO2 production and lung compliance.

LuSi responds autonomously

LuSi responds autonomously

LuSi responds to treatment without operator intervention and can simulate pathologies like RDS, lung collapse, weak muscular activity, pneumothorax, airway obstruction, etc. Models based on scientific literature, for example Latzin et.al. Lung Volume, Breathing Pattern and Ventilation Inhomogeneity in Preterm and Term Infants. PLoS One 2009:4/2 e4635

Trainer control software LuSiLIFE

Trainer control software LuSiLIFE

The design and selection of pathologies is controlled by LuSiLIFE, a touch screen enabled, pathology building and execution program. Execution of pre assembled cases, loading of patient case libraries, on-the-fly changes, notes taking and complete data recording for later analysis.

Integrated vital signs monitor

Integrated vital signs monitor

Use the Vital Signs Monitor window to display the results of treatment in real-time. Include pre-ductal and arterial pulse oximetry. Configure the monitor to match the device of your unit. Modify technical features of monitors, for example the rise time of capnometers, to teach potential and limitations for use in neonates.